Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
NYMOX PHARMACEUTICAL CORP (NYMX)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/14/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
08/02/2023 |
6-K
| Quarterly results |
07/31/2023 |
6-K
| Quarterly results |
07/25/2023 |
6-K
| Quarterly results |
07/25/2023 |
6-K
| Quarterly results |
07/12/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
|
"FORM 6-K",
"For Further Information Contact: Nymox Pharmaceutical Corporation 1-800-93NYMOX www.nymox.com Nymox Announces Appointment Of Patrick Doody as Vice President and Member of the Board of Directors of Nymox IRVINE, CA Nymox Pharmaceutical Corporation [OTC Markets – NYMXF] is pleased to announce the appointment of Patrick Doody as Nymox Vice President, General Counsel, and Member of Nymox Board of Directors. Mr. Doody joins Nymox from Pillsbury Winthrop Shaw Pittman LLP, where he was a partner in the Intellectual Property Group, and currently is Senior Counsel. Mr. Doody is a well-respected patent attorney with significant knowledge and experience in post-grant proceedings, patent infringement litigation, patent prosecution, licensing, opinions, and counseling. Mr. Doody has represented Nymox a..." |
|
06/29/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
05/12/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
01/06/2023 |
6-K
| Quarterly results |
11/14/2022 |
6-K
| Quarterly results |
11/10/2022 |
6-K
| Quarterly results |
08/15/2022 |
6-K
| Quarterly results |
07/07/2022 |
6-K
| Quarterly results |
05/13/2022 |
6-K
| Quarterly results |
03/22/2022 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
11/19/2021 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
11/12/2021 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
08/13/2021 |
6-K
| Quarterly results |
05/14/2021 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
05/06/2021 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
|
"FORM 6-K",
"Form of Investor Warrant",
"Form of Placement Agent Warrant",
"Placement Agent Agreement, between the Company and the Placement Agent",
"Form of Securities Purchase Agreement, between the Company and the investors party thereto",
"Registration Rights Agreement",
"NYMOX ANNOUNCES $8,000,000 PRIVATE PLACEMENT" |
|
11/20/2020 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
11/19/2020 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
11/13/2020 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
10/13/2020 |
6-K
| Quarterly results |
08/14/2020 |
6-K
| Quarterly results |
08/14/2020 |
6-K
| Quarterly results |
08/12/2020 |
6-K
| Quarterly results |
08/12/2020 |
6-K
| Quarterly results |
07/20/2020 |
6-K
| Quarterly results |
05/14/2020 |
6-K
| Quarterly results |
11/19/2019 |
6-K
| Quarterly results |
11/13/2019 |
6-K
| Quarterly results |
08/14/2019 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
05/15/2019 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
|
|
|